Stay updated on Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Sign up to get notified when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.

Latest updates to the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the previous study record content with a basic site layout indicating access is blocked.SummaryDifference15%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.6.6 has been added to the study record, replacing the previous v3.6.5 to indicate an applied update. The change represents a metadata refresh and does not modify the study details, eligibility criteria, or user-facing functionality.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a minor version update to the page rather than any alteration to study data.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, signaling a minor platform update. No study content or results appear to be affected.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a small page version update and no change to the study information or criteria.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a small maintenance update to the page rendering and metadata. No study data or content changes are indicated by this update.SummaryDifference0.1%

Stay in the know with updates to Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.